727 related articles for article (PubMed ID: 29476807)
1. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
2. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
Stepczynska A; Schanstra JP; Mischak H
Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
[TBL] [Abstract][Full Text] [Related]
3. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
[TBL] [Abstract][Full Text] [Related]
4. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
Eckhard U; Marino G; Butler GS; Overall CM
Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
[TBL] [Abstract][Full Text] [Related]
5. Multiplex assay for multiomics advances in personalized-precision medicine.
Popa ML; Albulescu R; Neagu M; Hinescu ME; Tanase C
J Immunoassay Immunochem; 2019; 40(1):3-25. PubMed ID: 30632882
[TBL] [Abstract][Full Text] [Related]
6. Quantitative protein biomarker panels: a path to improved clinical practice through proteomics.
Hartl J; Kurth F; Kappert K; Horst D; Mülleder M; Hartmann G; Ralser M
EMBO Mol Med; 2023 Apr; 15(4):e16061. PubMed ID: 36939029
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
8. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology.
Krasny L; Huang PH
Mol Omics; 2021 Feb; 17(1):29-42. PubMed ID: 33034323
[TBL] [Abstract][Full Text] [Related]
9. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
Manes NP; Nita-Lazar A
J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
[TBL] [Abstract][Full Text] [Related]
10. Translational -omics: Future potential and current challenges in precision medicine.
Wafi A; Mirnezami R
Methods; 2018 Dec; 151():3-11. PubMed ID: 29792918
[TBL] [Abstract][Full Text] [Related]
11. Targeted Proteomics for Studying Pathogenic Bacteria.
Saleh S; Staes A; Deborggraeve S; Gevaert K
Proteomics; 2019 Aug; 19(16):e1800435. PubMed ID: 31241236
[TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.
He B; Huang Z; Huang C; Nice EC
Proteomics Clin Appl; 2022 Nov; 16(6):e2100097. PubMed ID: 35490333
[TBL] [Abstract][Full Text] [Related]
14. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
15. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
16. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.
Narasimhan M; Kannan S; Chawade A; Bhattacharjee A; Govekar R
J Transl Med; 2019 May; 17(1):184. PubMed ID: 31151397
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
Hawkridge AM; Muddiman DC
Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
[TBL] [Abstract][Full Text] [Related]
18. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
[TBL] [Abstract][Full Text] [Related]
19. SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications.
Anjo SI; Santa C; Manadas B
Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 28127880
[TBL] [Abstract][Full Text] [Related]
20. Toward an integrated pipeline for protein biomarker development.
Drabovich AP; MartÃnez-Morillo E; Diamandis EP
Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
